2023 Form 5500 filing — Cti Biopharma Corp. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015063744NAL0015911411001) for Cti Biopharma Corp. 401(K) Plan, reported by Cti Biopharma Corp under EIN 91-1533912 and plan number 001. It reports 203 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015063744NAL0015911411001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Cti Biopharma Corp
- EIN
- 91-1533912
- Plan number
- 001
- Location
- Waltham, MA
- Participants
- 203
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $18,384,529
- Total liabilities (EOY)
- $66,098
- Net assets (EOY)
- $18,318,431
- Employer contributions
- $1,306,393
- Participant contributions
- $2,580,900
- Total income / additions
- $7,423,147
- Benefits paid
- $5,544,520
- Administrative expenses
- $23,338
- Total expenses
- $5,571,151
- Net increase / (decrease)
- $1,851,996
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Highland Capital Advisors, LLC. | INVESTMENT/FINANCIAL ADVI | $15,000 | $0 |
| Adp, Inc. | RECORD KEEPER | $8,338 | $0 |
| Adp Broker-Dealer | RECORD KEEPER | $0 | $0 |